Amarantus Bioscience Holdings, Inc. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/511b0d64-5c6a-4d54-831b-adac1d68803e/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-25.2M | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-013437 |
| FY 2014 | $-27.3M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-021238 |
| FY 2013 | $-32.2M | 2008-01-14 – 2014-03-31 | evidence 0001144204-14-032563 |
| FY 2012 | $-14.3M | 2008-01-14 – 2013-03-31 | evidence 0001255294-13-000348 |
| FY 2011 | $-7.7M | 2008-01-14 – 2012-03-31 | evidence 0001255294-12-000340 |
| FY 2010 | $-1.2M | 2010-01-01 – 2010-12-31 | evidence 0001255294-12-000249 |
| FY 2009 | $-306.2k | 2009-01-01 – 2009-12-31 | evidence 0001255294-12-000249 |
| FY 2008 | $-406.7k | 2008-01-14 – 2008-12-31 | evidence 0001255294-12-000249 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Amarantus Bioscience Holdings, Inc. — all facts · Revenue · Operating Income